Effectiveness of Brucellosis on Polymorphisms of IL-1B and IL-10 Concentrations Among Iraqi Patients
DOI:
https://doi.org/10.55544/jrasb.2.6.34Keywords:
Brucellosis, Polymorphisms, IL-1B, IL-10Abstract
In this study, (60) blood samples were taken from patients infected with brucellosis, and (60) samples were taken from healthy individual as a control group. The patients were visiting Emam Ali Hospital for Fever in Baghdad city, during the period from 1st February to 1st November 2023. The results of gender distribution showed that among patients infected with Brucellosis, 30 (50.0%) were males and 30 (50%) were females, while among the control group, 31(51.7%) were males and 29(48.3%) were females. Also the distribution of infections according residency were matched between urban and rural locations 30(50.0%) for both. While the distribution of Brucellosis among age groups showed that the highest incidence of infection was in the age groups (40-50) years and (17-29) years 22(36.7%) for each, followed by the age group (30-39) years 16(26.7%). The mean levels of anti Brucella antibodies IgM, IgG, IL-10, IL-1B in patients with brucellosis were (0.11±0.17), (0.09±0.15), (5.62±1.99), (4.92±1.76) respectively compared to their mean levels in the control group (2.01±1.17), (1.33±0.59), (60.68±26.81), (22.85±9.17) respectively with highly significant differences (p<0.01). The ROC test showed that the Sensitivity of Brucella IgM concentration was100% and Specificity 100% in Cut off >0.84. Also the Sensitivity of Brucella IgG concentration was 100% and Specificity 100% in Cut off >0.33. Also the Sensitivity of IL-10 concentration was 100% and Specificity 100% in Cut off >18.04, and the Sensitivity of IL-1B concentration was 100% and Specificity 100% in Cut off >9.08. There were mutations occurred with IL-1B gene ID 3553 in SNPs, rs1143627. The variation of wild TT was changed to CC, CC, TC, TC, CC, AG, CC, TC in 8 cases out of 11 in comparison with the control group, and the mutation occurred with IL-1B gene ID 3553 in SNPs, rs1143627. The variation of wild TT was changed to CC, CC, TC, TC, CC, AG, CC, TC in 8 cases out of 11 in comparison with the control group.
Downloads
Metrics
References
Khoshnood, S. Reza Pakzad, R. and Maryam Koupaei, M et al. Prevalence, diagnosis, and manifestations of brucellosis: A systematic review and meta-analysis, Front. Vet. Sci. J. V. 9 - 2022 | https://doi.org/10.3389/fvets.2022.976215.
Hassan L, Ali S, Syed MA, Shah AA, Abbasi SA, Tabassum S, et al.. Risk factors for acute brucellosis in patients on the day of admission at selected hospitals of Abbottabad, Pakistan. Front Public Health. (2021) 9:669278. 10.3389/fpubh.2021.669278.
Al Jindan R. Scenario of pathogenesis and socioeconomic burden of human brucellosis in Saudi Arabia. Saudi J Biol Sci. (2021) 28:272–9. 10.1016/j.sjbs.2020.09.059.
Zheng R, Xie S, Lu X, Sun L, Zhou Y, Zhang Y, et al.. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. BioMed Res Int. (2018) 2018:5712920. 10.1155/2018/5712920.
Avijgan M, Rostamnezhad M, Jahanbani-Ardakani H. Clinical and serological approach to patients with brucellosis: a common diagnostic dilemma and a worldwide perspective. Microbial Pathog. (2019) 129:125–30. 10.1016/j.micpath.2019.02.011.
Abdel-Hamid NH, Ghobashy HM, Beleta EI, Elbauomy EM, Ismail RI, Nagati SF, et al.. Risk factors and Molecular genotyping of Brucella melitensis strains recovered from humans and their owned cattle in Upper Egypt. One Health. (2021) 13:100281. 10.1016/j.onehlt.2021.100281.
Wang X, Jiang H. Global prevalence of human brucellosis. Zhonghua Liu Xing Bing Xue Za Zhi. (2020) 41:1717–22. 10.3760/cma.j.cn112338-20191022-00751.
Soltani S, Zandi M, Faramarzi S, Shahbahrami R, Vali M, Rezayat SA, et al.. Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis. Osong Public Health Res Perspect. (2022) 13:15–23. 10.24171/j.phrp.2021.0293.
Pakzad R, Malekifar P, Shateri Z, Zandi M, Akhavan Rezayat S, Soleymani M, et al.. Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: a comprehensive updated systematic review and meta-analysis. J Clin Lab Anal. (2022) 36:e24151. 10.1002/jcla.24151.
Ntirandekura JB, Makene VA, Kasanga CJ, Matemba LE, Kimera SI, Muma JB, et al.. Molecular characterization of Brucella species detected in humans and domestic ruminants of pastoral areas in Kagera ecosystem, Tanzania. Vet Med Sci. (2020) 6:711–9. 10.1002/vms3.298.
Chen, Ch. and Maree T. Smith2, M. T. The NLRP3 inflammasome: role in the pathobiology of chronic pain, Inflammopharmacology (2023) 31:1589–1603 doi.org/10.1007/s10787-023-01235-8.
Cowie, A. M. Bonnie N. Dittel, B. N. and Stucky, Ch. L. et al., A Novel Sex-Dependent Target for the Treatment of Postoperative Pain: The NLRP3 Inflammasome, Front. Neurol., 12 June 2019Sec. Multiple Sclerosis and Neuroimmunology 2019 | doi.org/10.3389/ fneur.2019.00622.
Iyer, Sh. S. and Cheng, G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease, Crit Rev Immunol. 2012; 32(1): 23–63. doi: 10.1615/critrevimmunol.v32.i1.30.
Rodríguez-Zapata, M. Matías, M. J. and Prieto, A. et al., Human Brucellosis Is Characterized by an Intense Th1 Profile Associated with a Defective Monocyte Function, Infect Immun. 2010 Jul; 78(7): 3272–3279. doi: 10.1128/IAI.01385-09.
Salmanzadeh S, Aliakbarian Z, Mostafavi E, Salehi-Vaziri M, Moogahi S. A cross-sectional study of sero-prevalence and risk factors of brucellosis and haemorrhagic fever in slaughterhouse staff in Ahvaz City, Iran. Med Stud Studia Medyczne. (2020) 37:7–15. 10.5114/ms.2021.104995.
Yousaf R, Khan I, Shehzad W, Hussain R, Ali S, Neubauer H, et al.. Seroprevalence and molecular detection of brucellosis in hospitalized patients in Lahore hospitals, Pakistan. Infect Dis Rep. (2021) 13:166–72. 10.3390/idr13010018.
Guzmán-Bracho C, Salgado-Jiménez B, Beltrán-Parra LG, Hernández-Monroy I, Vargas-Pino F, Rodríguez D, et al.. Evaluation of serological diagnostic tests of human brucellosis for prevention and control in Mexico. Eur J Clin Microbiol Infect Dis. (2020) 39:575–81. 10.1007/s10096-019-03760-3.
Tang, Y. Chenjie Ma, Ch. and Sun, H. et al., Serum Levels of Seven General Cytokines in Acute Brucellosis Before and After Treatment, Infect Drug Resist. 2021; 14: 5501–5510. doi: 10.2147/IDR.S341331.
Sun, H-Li. Du, X. and Tang, Y-X. Impact of immune checkpoint molecules on FoxP3+ Treg cells and related cytokines in patients with acute and chronic brucellosis, BMC Infect Dis. 2021; 21: 1025. Published online 2021 Sep 30. doi: 10.1186/s12879-021-06730-3.
Demirdag, K. Ozden, M. and Kalkan, A. et al., Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers, FEMS Immunology and Medical Microbiology, V. 39, Issue 2, 28 November 2003, Pages 149-153.
Jin, X. Yueyuan Wu, Y. Shuzhou Yin, Sh. Xu Chen, Xu. and Youtao Zhang. Y. Association between the IL-10 and IL-6 polymorphisms and brucellosis susceptibility: a meta-analysis, BMC Med Genet. 2020; 21: 63. doi: 10.1186/s12881-020-01006-0
Etemadi A, Moniri R, Saffari M, Akbari H, Alamian S, Behrozikhah AM. Epidemiological, molecular characterization and risk factors of human brucellosis in Iran. Asian Pac J Trop Med. (2020) 13:169. 10.4103/1995-7645.280224.
ZGHAIR, ABDULRAZZAQ NEAMAH; MOHAMMED, NAZAR SH; MUHSIN, SALWA S. Change in CRT gene sequence of Plasmodium falsiparum as a chloroquen resistant in Iraqi patients. International Journal of Pharmaceutical Research (09752366), 2020, 12.2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bushra Qasim Dhumad
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.